Strota/ Newsroom/ 2026-07-11

ORCHPHARMA (ORCHPHARMA): Acquisition / M&A

Strota Newsroom · session of 2026-07-11 · 10 Jul 20:36 · ORCHPHARMA stock page →

Orchid Pharma Limited has informed the Exchange that Record date for the purpose of Merger/HiveOff is 23-Jul-2026. Historically, acquisition / m&a events have moved ORCHPHARMA-type stocks in the bullish direction 48.9% of the next sessions (n=141).

Orchid Pharma has informed the exchange that the record date for its merger with Dhanuka Laboratories is set for 23-July-2026, according to an NSE filing dated 10 July. The company also noted the board's approval of the scheme of amalgamation, which will see Dhanuka Laboratories merge into Orchid Pharma with effect from the appointed date. The filing was made under Regulation 30 of SEBI's listing regulations.

Events like this—merger record-date announcements—have historically shown a 48.9% win rate across 141 comparable instances in Strota's database, with a net edge of 0.213%. This base rate reflects how similar corporate actions have performed in the past across many stocks, not a forecast for Orchid Pharma specifically.

The stock currently trades at a price-to-earnings ratio of 246.96 and a price-to-book of 3.99, with earnings per share at ₹4.1. Its market capitalisation stands at ₹5,136 crore. The Nifty 50 rose 1.02% on the session.

The filing establishes the timeline for the amalgamation and the board's formal noting of the scheme. It does not specify financial terms of the merger, synergies expected, or any change to the company's capital structure beyond what the exchange filing describes.

The catalyst

Orchid Pharma Limited has informed the Exchange that Record date for the purpose of Merger/HiveOff is 23-Jul-2026. (filing · NSE)

What the data shows after this event

Across Strota's backtest of past filings, Acquisition / M&A shows no reliable next-session edge — the move went bullish in about 48.9% of next sessions (net 0.213% after drift and cost, n=141). A base rate, not a forecast for this stock.

ORCHPHARMA right now

P/E 246.96. Full ORCHPHARMA analysis →

Sources

Orchid Pharma Limited has informed the Exchange that Record date for the purpose of Merger/HiveOff is 23-Jul-2026. — NSE
Orchid Pharma Finalizes Merger with Dhanuka, Boosts Authorised Capital and Sets Record Date — TipRanks
ORCHPHARMA Forecast — Price Target — Prediction for 2027 — TradingView
NSE:ORCHPHARMA-Idee Chartbild von MandeepSinghKohli — TradingView
Some May Be Optimistic About Orchid Pharma's (NSE:ORCHPHARMA) Earnings — simplywall.st

Keep digging

ORCHPHARMA — full smart-money page: F&O positioning, deals, insider filings and option chain in one place.
Today's screens: every stock matching the same setups (buildups, breakouts, volume shockers).
Newsroom: the other stocks in play this session.

How this article was made: Strota assembled the exchange data above (prices, F&O open interest, bulk/block deals, SEBI PIT filings, indicator readings and public headlines) and an AI model wrote the narrative strictly from that evidence — it is not permitted to add outside facts or numbers. Every figure comes from the underlying exchange/public data.